PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, San Raffaele Hospital, Milano, Lombardia, Italy dellatorre.emanuel@hsr.it dagna.lorenzo@unisr.it.\', \'Università Vita-Salute San Raffaele, Milan, Italy.\', \'Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, San Raffaele Hospital, Milano, Lombardia, Italy.\', \'Clinical and Experimental Radiology Unit, Experimental Imaging Center, San Raffaele Hospital, Milan, Italy.\', \'General Medicine and Advanced Care Unit, San Raffaele Hospital, Milan, Italy.\', \'Internal Medicine, Diabetes & Endocrinology Unit, San Raffaele Hospital, Milan, Italy.\', \'Hematology and Bone Marrow Transplant Unit, San Raffaele Hospital, Milan, Italy.\', \'Department of Anesthesia and Intensive Care, San Raffaele Hospital, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2020-218122
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 32620597
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all